Literature DB >> 25310641

The changing epidemiology of thyroid cancer: why is incidence increasing?

Riccardo Vigneri1, Pasqualino Malandrino, Paolo Vigneri.   

Abstract

PURPOSE OF REVIEW: Thyroid cancer incidence is increasing worldwide. Causes are highly debated. RECENT
FINDINGS: Thyroid cancer increase has been associated to socioeconomic status, better access to healthcare and rising use of thyroid imaging. Therefore, the rise could be apparent because of the useless identification of a large reservoir of subclinical papillary lesions that will never affect patient health (overdiagnosis).However, not all epidemiological and clinical data support this hypothesis. The increasing number of large tumors, the increasing thyroid cancer-related mortality in spite of earlier treatment and the changes in thyroid cancer molecular profile suggest a true increase. Recently increased and thyroid-specific environmental carcinogens could be responsible, such as radiation (mostly medical radiation), increased iodine intake and chronic lymphocytic thyroiditis and environmental pollutants such as nitrates, heavy metals and other compounds largely used in the industrialized society. Possible mechanisms await further investigation.
SUMMARY: The increased incidence of thyroid cancer is the likely result of two coexisting processes: increased detection (apparent increase) and increased number of cases (true increase) due to unrecognized thyroid-specific carcinogens.To identify causal factors and to differentiate stationary cancers from those that will progress are major urgent requirements for both clinical and scientific purposes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25310641     DOI: 10.1097/CCO.0000000000000148

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  85 in total

1.  The 8q24 rs6983267G variant is associated with increased thyroid cancer risk.

Authors:  Ruta Sahasrabudhe; Ana Estrada; Paul Lott; Lynn Martin; Guadalupe Polanco Echeverry; Alejandro Velez; Gila Neta; Meiko Takahasi; Vladimir Saenko; Norisato Mitsutake; Emma Jaeguer; Carlos Simon Duque; Alejandro Rios; Mabel Bohorquez; Rodrigo Prieto; Angel Criollo; Magdalena Echeverry; Ian Tomlinson; Luis G Carvajal Carmona
Journal:  Endocr Relat Cancer       Date:  2015-08-19       Impact factor: 5.678

2.  Contrast-enhanced ultrasound and real-time elastography in the differential diagnosis of malignant and benign thyroid nodules.

Authors:  Xin Sui; Huai-Jun Liu; Hong-Li Jia; Qin-Mao Fang
Journal:  Exp Ther Med       Date:  2016-05-17       Impact factor: 2.447

3.  Incidental detection, imaging modalities and temporal trends of differentiated thyroid cancer in Ontario: a population-based retrospective cohort study.

Authors:  Todd A Norwood; Emmalin Buajitti; Lorraine L Lipscombe; Thérèse A Stukel; Laura C Rosella
Journal:  CMAJ Open       Date:  2020-11-02

4.  Increased thyroid cancer incidence in a basaltic volcanic area is associated with non-anthropogenic pollution and biocontamination.

Authors:  Pasqualino Malandrino; Marco Russo; Anna Ronchi; Claudio Minoia; Daniela Cataldo; Concetto Regalbuto; Carla Giordano; Marco Attard; Sebastiano Squatrito; Francesco Trimarchi; Riccardo Vigneri
Journal:  Endocrine       Date:  2015-10-05       Impact factor: 3.633

5.  Combined BRAFV600E analysis and 99mTc-MIBI scintigraphy can be a useful diagnostic tool in differentiated thyroid cancer patients with incomplete bio-chemical response to first radioiodine therapy (RAIT): a pilot investigation.

Authors:  A Campennì; R M Ruggeri; M Siracusa; S A Pignata; F Di Mauro; A Vento; F Trimarchi; S Baldari
Journal:  J Endocrinol Invest       Date:  2018-03-16       Impact factor: 4.256

6.  Clinical and pathologic predictors of central lymph node metastasis in papillary thyroid microcarcinoma: a retrospective cohort study.

Authors:  C Y Gui; S L Qiu; Z H Peng; M Wang
Journal:  J Endocrinol Invest       Date:  2017-09-07       Impact factor: 4.256

7.  Does the ATA Risk Stratification Apply to Patients with Papillary Thyroid Microcarcinoma?

Authors:  Dessislava I Stefanova; Arpita Bose; Timothy M Ullmann; Jessica N Limberg; Brendan M Finnerty; Rasa Zarnegar; Thomas J Fahey; Toni Beninato
Journal:  World J Surg       Date:  2020-02       Impact factor: 3.352

8.  Hysterectomy, Oophorectomy, and Risk of Thyroid Cancer.

Authors:  Juhua Luo; Michael Hendryx; JoAnn E Manson; XiaoYun Liang; Karen L Margolis
Journal:  J Clin Endocrinol Metab       Date:  2016-07-26       Impact factor: 5.958

9.  BRAF(V600E) Mutation is Associated with Decreased Disease-Free Survival in Papillary Thyroid Cancer.

Authors:  S Fraser; C Go; A Aniss; S Sidhu; L Delbridge; D Learoyd; R Clifton-Bligh; L Tacon; V Tsang; B Robinson; A J Gill; M Sywak
Journal:  World J Surg       Date:  2016-07       Impact factor: 3.352

10.  Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population.

Authors:  Kai Yuan; Meiling Huo; Yong Sun; Hongyan Wu; Hongqiang Chen; Yulong Wang; Rongzhan Fu
Journal:  Tumour Biol       Date:  2015-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.